This K23 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $194,911 to Yale University to conduct research and develop an intervention to facilitate timely and equitable peanut allergy prevention in high-risk infants.
The key objectives of the project are to: 1) Explore sociodemographic determinants of peanut introduction timing in high-risk infants, 2) Examine facilitators and barriers to guideline-concordant peanut allergy prevention care, and 3) Pilot a virtual visit-based intervention to promote peanut introduction by 6-12 months in an urban, underserved population. The research aims to provide insights to address disparities in peanut allergy prevalence and care access, building on prior work that demonstrated an electronic health record-based intervention can improve guideline-adherent management. The award period runs from August 2024 to July 2028.